SPOT Directional Report

Analysis based on market close March 31, 2026

Outlook

Neutral with a slight upward bias toward the $490-$500 zone, but trapped in a wide, high-volatility range. Confidence: 5.5/10. The regime is contradictory: positive GEX suggests pinning, but net negative premium and mixed flow signal underlying uncertainty. Spot is caught between near-term max pain magnets and distant structural OI walls.

Confidence:

5.5 / 10

Base 5.5 stands. +1 for GEX pinning near spot; -0.5 for net premium flow contradicting bullish pin; -0.5 for extremely high IV (59%) adding noise; +0.5 for spot proximity to near-term max pain.

Supports: Positive GEX (+$559K) and DEX (+3.9M shares) support pinning. Spot is within 1% of 3/27 max pain ($490).
Conflicts: Net premium flow is negative (-$18.8M) despite positive GEX. IV is extremely elevated at 59%, suggesting high uncertainty. P/C ratios are neutral (1.06 vol, 1.02 OI).

⚠️Extreme IV (59%) dominates all strategies — premium selling has edge but high risk.

📌Spot pinned between $490 (3/27) and $477.5 (4/2) max pain levels.

Regime Classification

Vol Regime

High

IV 59% is extremely high — favors premium selling and defined-risk spreads over long vol.

Gamma Regime

Pinning

GEX +$559K is positive but small relative to price, indicating mild pinning pressure near spot, not a strong magnet.

Flow Regime

Mixed

Mixed — net premium negative suggests put buying or call selling, but P/C ratios are neutral, showing no clear directional consensus.

Spot vs Max Pain

Below

Spot $484.91 is below 3/27 MP ($490) but above 4/2 MP ($477.5), caught between conflicting near-term pins.

Thesis duration: Multi-week — Max pain ladder shows a rising trend from $477.5 to $500+ over the next month, and GEX sign is stable positive. The high-volatility, range-bound regime is likely to persist beyond a single expiry.

Price Range Forecast

Next 2 days

$468.39$501.44

Max pain at $490 for 3/27 expiry provides a mild upward pull. Break below $468.39 (2d EM low) invalidates.

Next 1 week

$456.59$513.24

Pinned between 4/2 and 4/24 max pain levels. A move above $513.24 (1w EM high) signals breakout.

Next 2 weeks

$446.99$522.84

Max pain rises to $500 by 4/24 and $520 by 6/18. Structural call OI at $540-$660 caps major rallies.

Key Levels

Max pain pins: $490 (2026-03-27); $478 (2026-04-02); $485 (2026-04-10)

EM guardrails: 2d $468.39/$501.44; 1w $456.59/$513.24

Support: $410.00 · $100.00 · $350.00

Resistance: $600.00 · $500.00 · $600.00

Gamma flip: ~$410.00 — Approx — based on put OI concentration of 2,079

Structural: **Call OI wall $540-$660** (OI 1,339-3,043) is a major upside cap. **Put floor $100-$410** (OI 1,718-2,079) is far below and not a near-term support; the $410 gamma flip is the first meaningful level.

Dealer Positioning (GEX/DEX)

GEX: $+559K

DEX: +3.9M shares

Gamma flip: ~$410 (Approx — based on put OI concentration of 2,079)

NTM gamma: Gamma flip at ~$410 is far below spot, indicating dealers are long gamma (hedging is stabilizing) only on a severe drop. Near-term, dealer hedging flows are minimal, offering little resistance to moves within the expected range.

IV Analysis

IV vs VIX: IV 59% is extreme — SPOT vol is rich vs. any broad market measure, creating a strong environment for selling premium.

Term structure: **Steeply inverted**: 2d IV 56.5% > 10d IV 43.0%. A major kink at 5/01 (IV 55.4%) likely prices the 4/28 earnings event. This supports selling near-term and buying longer-dated vol (calendar spreads).

Skew: **~13.5 vol-point differential** between 4/2 (56.5%) and 4/10 (43.0%) expiries — a prime setup for a short calendar (sell near, buy far) to capture the steep inversion decay.

Flow Analysis

Net premium: Net $-18.8M bearish, but P/C ratios are neutral (1.06 vol, 1.02 OI), indicating the bearish flow is not overwhelmingly one-sided.

Directional prints: $460P 4/17 vol 704 vs OI 256 (2.8x) at IV 45.9% — could be protective put buying or opening of bearish spreads. $240P 7/17 vol 350 vs OI 196 (1.8x) at IV 72.6% — likely a far OTM hedge or speculative lottery ticket.

Unusual: Massive net negative premium at ultra-high strikes ($700, $740 puts) — this is almost certainly **far OTM put selling** (premium collection), not directional bearish bets, explaining the net negative premium despite neutral P/C ratios.

Risks & Catalysts

!**Gamma flip at $410** — a break below this level could trigger accelerated selling due to dealer hedging.

!**Earnings on 4/28** — priced into the 5/01 IV kink (55.4%); expect massive vol crush post-event.

!**Extreme IV (59%)** — while good for sellers, it implies high underlying volatility risk; long options are expensive.

!**Low liquidity / moderate OI** — GEX and max pain signals are weaker than in mega-caps; wider spreads.

Strategy Viability

Strategy	Edge	Best Setup	Primary Risk
Iron condor	Moderate-Weak	Sell $460/$455P & $505/$510C, 4/17 expiry. Wings at 1w EM bounds.	GEX is positive, but VIX proxy >28 (IV 59%) adds tail risk. Defined risk helps.
Cash-secured put / put spread	Moderate-Strong	Sell $460/$455 put spread 4/17, or CSP at $460. Targets 1w EM low and below near-term max pain.	Break below $456.59 (1w EM low).
Covered call	Moderate	Own stock, sell $500C 4/24. At resistance from max pain and call OI.	Capped upside if stock rallies toward $500+.
Long calls	Weak	Avoid. IV 59% is punitive for long premium. If bullish, use spreads.	Vol crush and time decay.
Long puts / bear put spread	Moderate-Weak	If bearish, buy $480/$475 put spread 4/10. Defined risk below spot.	High IV and positive GEX work against it.
Calendar/diagonal spread	Strong	Short Calendar: Sell $485C 4/2 (IV 56.5%), Buy $485C 4/10 (IV 43.0%). Capture ~13.5 vol pts.	Directional move through short strike.
PMCC / LEAPS diagonal	Moderate-Strong	Buy $410C Jan 2027 (IV ~48.4%), sell $500C against it monthly (e.g., 4/24). Leverages long-term bullish max pain trend.	Capital intensive; stock stagnation.
Short stock	Weak	Not recommended. Positive GEX and rising max pain trend provide upward pressure.	Squeeze toward $490-$500.
Long stock	Moderate	Entry near $477.5 (4/2 max pain) with target $500. Aligns with multi-week max pain drift.	High beta and IV environment.

Top Plays

Short Put Spread

Sell $460/$455 Put Spread, 4/17 expiry

Capitalizes on high IV for premium sale, positive GEX pinning, and places short put at the 1-week expected move low ($456.59). Defined risk below the key gamma flip.

Credit: $1.10-$1.30

Max loss: $3.90

BE: $458.90

Mgmt: Take profit at 60-70% of max credit. Exit if spot closes below $456.59 (1w EM low).

Traders with a neutral-to-bullish bias seeking defined-risk income in a high-vol environment.

Short Calendar Call

Sell $485C 4/2, Buy $485C 4/10

Exploits the steep 13.5 vol-point inversion in term structure. Best if spot stays near $485 through 4/2 expiry. The extra week in the long leg improves risk/reward by providing continued long exposure after the expensive short vol decays.

Credit: $2.50-$3.50

BE: Complex; manage on short leg decay.

Mgmt: Close when short leg IV collapses post-4/2 expiry or if spot moves >$5 away from $485. Roll short leg if challenged.

Volatility traders looking to capitalize on term structure mispricing with minimal directional bias.

PMCC (Diag. Call Spread)

Buy $410C Jan 2027, Sell $500C 4/24

Expresses a multi-week bullish thesis aligned with the rising max pain trend ($477.5 → $500+). The LEAPS provides low-time-decay exposure, while the short call generates income against the $500 resistance (max pain & call OI). Better than a naked long call due to cost basis reduction.

Debit: $75.00-$85.00

Max loss: Cost of LEAPS

BE: Stock price > (LEAPS cost + $500C credit) by Jan 2027

Mgmt: Roll short calls up and out monthly, targeting strikes near resistance. Close if long-term max pain trend breaks (e.g., spot < $470 for multiple weeks).

Investors with a multi-month bullish view and sufficient capital to deploy a LEAPS.

Watchlist Triggers

Entry Triggers

IFSpot dips to $477.5 (4/2 max pain) and holds → Enter long stock or sell $460/$455 put spread 4/17.

IFIV term structure remains inverted (>10 vol pts between 4/2 and 4/10) → Initiate short calendar: sell $485C 4/2, buy $485C 4/10.

Exit Triggers

EXITPost-4/28 earnings, IV on 5/01 expiry collapses >20% → Take profit on all short premium positions (put spreads, calendars).

EXITSpot closes above $513.24 (1w EM high) → Exit short call positions and consider long delta (stock, call spreads).

Tactical Summary

Primary thesis: High-volatility range trade with a multi-week bullish drift toward $500. Favor selling premium (puts, calendars) due to extreme IV, using expected move bounds and max pain levels for strike selection. Invalidation is a close below the 1-week EM low ($456.59). Top plays: 1) Put spread for defined-risk income, 2) Calendar for vol structure arb, 3) PMCC for longer-term bullish exposure with income.

Read the Directional analysis for SPOT for 2026-03-31. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.